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VLGR1 (very large G protein-coupled receptor 1), also known as
MASS1 (monogenic audiogenic seizure susceptible 1), is an orphan
G protein-coupled receptor that contains a large extracellular N
terminus with 35 calcium-binding domains. A truncating mutation
in theMass1 gene causes autosomal recessive, sound-induced seiz-
ures in the Fringsmouse. However, the function of MASS1 and the
mechanism underlying Frings mouse epilepsy are not known.
Here, we found that MASS1 protein is enriched in the myelinated
regions of the superior and inferior colliculi, critical areas for the
initiation and propagation of audiogenic seizures. Using a panel of
myelin antibodies, we discovered that myelin-associated glycopro-
tein (MAG) expression is dramatically decreased in Frings mice.
MASS1 inhibits the ubiquitylation of MAG, thus enhancing the sta-
bility of this protein, and the calcium-binding domains of MASS1 are
essential for this regulation. Furthermore, MASS1 interacts with
Gαs/Gαq and activates PKA and PKC in response to extracellular cal-
cium. Suppression of signaling byMASS1 RNAi or a specific inhibitor
abrogates MAG up-regulation. We postulate that MASS1 senses
extracellular calcium and activates cytosolic PKA/PKC pathways to
regulate myelination by means of MAG protein stability in myelin-
forming cells of the auditory pathway. Further work is required to
determinewhether MAG dysregulation is a cause or consequence of
audiogenic epilepsy and whether there are other pathways regu-
lated by MASS1.
genetics | molecular basis
Epilepsy is a complex brain disorder with recurrent and un-provoked seizures affecting ∼2.5% of the population (1). In
a majority of epilepsy cases, the precise trigger of seizure in-
duction is not understood but is often associated with various
precipitants such as stress, fatigue, menstruation, alcohol in-
gestion, and dehydration. However, in the reflex epilepsies, the
trigger can be remarkably specific. Flickering light, reading, startle,
touch, or specific types of music are each known to precipitate
seizures in different patients (2).
The Fringsmouse has monogenic audiogenic seizures, for which
the causative gene has already been identified, thereby making it
an outstanding animal model for more detailed study of reflex
epilepsy pathogenesis (3). The Frings mutation arose spontane-
ously on the Swiss albino genetic background. In response to
a high-intensity sound (110-dB, 11-kHz tone stimulus of 20 s du-
ration), mutant mice exhibit wild running, loss of righting reflex,
tonic flexion, and tonic extension seizures (3). A 1-bp deletion
leads to premature truncation of the very large G protein-coupled
receptor 1 (VLGR1)/monogenic audiogenic seizure susceptible 1
(MASS1) (hereafter referred to as “MASS1”) protein and causes
the audiogenic seizures in Frings mice (4). There are two Mass1-
specific knockout mice, which either deleted exons 2–4 (5) or after
exon 82 covering the transmembrane and carboxyl terminus of
Mass1 (6). Both of them showed the same audiogenic seizures in
response to high-intensity sound like the Frings mice. MASS1 is
expressed in brain, kidney, and cochlea, although finer detail
regarding cell type-specific expression is not available. It is an
∼700-kDa orphan G protein coupled receptor (GPCR) having sev-
eral known domains. They include 35 CalX-β domains, a Pentraxin
domain, and an epilepsy-associated repeat (EAR) (4, 7). In par-
ticular, CalX-β is known to be a calcium-binding regulatory region
found in sodium–calcium exchangers (8), and the presence of 35 of
these domains in the extracellular N terminus of MASS1 suggests
that calcium may be an important regulator of MASS1. An addi-
tional clue regarding the function of MASS1 comes from recent
evidence that MASS1 is required for normal maturation of audi-
tory hair bundles (9). Stereocilia of cochlear hair cells are coupled
to one another by a number of different link types (tip links,
horizontal top connectors, shaft connectors, and ankle links) (10).
Examination of a targeted knockout of Mass1 showed that ankle
links failed to form in the cochlea, and the hair bundles became
disorganized after birth. However, the underlying seizure mecha-
nism in MASS1-deficient mice is still enigmatic.
Here we show that MASS1 regulates myelin-associated glyco-
protein (MAG) expression via Gαs/Gαq and PKA/PKC in response
to calcium in myelinated regions of superior and inferior colliculi
(SC and IC, respectively), sites known to be critical for the initi-
ation and propagation of audiogenic seizures (11). This evidence
that mutation of a GPCR causes a mammalian epilepsy, possibly
via dysregulation of a myelin protein, may provide insight into
novel intracellular signaling pathways in epileptogenesis.
Results
MASS1 Is Expressed in Oligodendrocytes. As part of our initial in-
vestigation of MASS1 function, we conducted immunohisto-
chemical analyses of brain sections from control and Frings mice
using a polyclonal MASS1 antibody (12), which was generated against
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the cytoplasmic tail (amino acids 6198–6307). Interestingly, the
MASS1 protein was highly enriched in the SC and IC (Fig. 1A).
The IC (and to a lesser extent, the SC) are nuclei in the auditory
pathway and have important roles in audiogenic seizure initia-
tion/propagation (11). No immunoreactivity of MASS1 was seen
in Frings mouse brain. Next, the sections were colabeled with
antibodies against MASS1 and either proteolipid protein (PLP)
[oligodendrocytes (OLs)], NeuN (neurons), or GFAP (astro-
cytes). MASS1 signal overlapped with that of PLP but not other
markers, suggesting that MASS1 is enriched in OLs (Fig. 1B).
Expression of MASS1 in OLs was further confirmed by RT-PCR
in total RNA extracts of purified primary OLs from both Frings
and control mice (Fig. 1C). Mass1 transcript was expressed in
both OLs and kidney cell lines but not in astrocytic or neuronal
cell types. Expression of Mass1 transcript in the kidney has
previously been reported (4), although its function in kidney is
unknown. To confirm MASS1 expression in myelin-forming OL
cells, myelin fractions were purified from both Frings and con-
trol mice (Fig. S1), and myelin protein complex was precipitated
using anti-MBP (myelin basic protein) antibody. MASS1 was
present in the myelin fraction associated with MBP. Taken
together, they suggest that MASS1 is expressed in myelin-forming
cells. However, we could not exclude the possibility of MASS1 ex-
pression in other types of brain cells in a spatiotemporal manner.
Reduced MAG Expression in Frings Mice. OLs are myelin-forming
cells in the central nervous system (CNS), and their growth and
differentiation are regulated by many factors: metabolites such
as glucose and lactate (13), microRNAs (14, 15), and proteins
(16). Therefore, to test the effects of MASS1 on physiology of
OLs, we quantified major myelin proteins in both Frings and
control brain homogenates. At all ages examined, MAG expression
is dramatically decreased in the Frings mouse, whereas MBP, my-
elin oligodendrocyte glycoprotein (MOG), 2′,3′-Cyclic-nucleotide
3′-phosphodiesterase (CNPase), and PLP are not significantly
changed (Fig. 2A). To further confirm reduced MAG expression,
we prepared primary OLs by differentiating them from purified
oligodendrocyte progenitor cells (OPCs). In cultured Frings OLs,
MAG protein expression is significantly reduced compared with
that of control. However, semiquantitative RT-PCR revealed that
Mag mRNA levels were not different in mutant vs. control mice,
implying that MASS1 regulates MAG posttranscriptionally (Fig.
2B). Immunohistochemical staining confirmed that MAG ex-
pression is significantly reduced in the SC and IC of the Frings
mice but not in the corpus callosum (Fig. 2C), indicating that
MASS1 in the colliculi might regulate MAG expression but not
in corpus callosum where MASS1 is not enriched. Thus, there
are likely other pathways affecting MAG expression. An OL
marker (CC1) was included and showed no obvious differences in
overall OL populations. Furthermore, there were no discernible
differences between Frings and controls in the differentiation
status of purified OLs as assessed by markers of mature OLs—
MBP and galactosylceramide (GalC; O1) (Fig. 2D).
MASS1 Regulates MAG Stability. Expressing exogenous MASS1 is
difficult given the size of the cDNA (∼20 kb). Therefore, we
generated a partial MASS1 construct (miniMass1) containing the
recognized functional domains of MASS1 (Fig. S2A). Mini-
MASS1 includes the signal peptide, four copies of the calcium-
binding domain (CalX-β), the EAR and Pentraxin domains,
GPCR-proteolytic site, seven transmembrane segments, and the
intracellular carboxyl terminal region. Additionally, we constructed
a miniMass1 lacking CalX-β domains (miniMass1ΔCalX-β) to test
calcium-specific effects, and a Mass1 C terminus harboring
only the intracellular carboxyl terminus of MASS1 (Fig. S2A).
GST-tagged clones for Mag, Mass1 C terminus, and the Mass1
third cytoplasmic loop were also generated for overexpression
(Fig. S2B).
Expression of MAG protein in COS-7 cells was dramatically
increased in a calcium-dependent manner when cotransfected
with miniMass1 vs. empty vector (Fig. 3A). We tested whether
the increased MAG resulted from altered degradation by treat-
ing transfected cells with cycloheximide before collecting cells at
Fig. 1. MASS1 is enriched in SC and IC. (A) SC and IC of control mice showed
strong MASS1 immunostaining (green), whereas no signal was seen in Frings
mice. (B) Double immunostaining for MASS1 (green) and markers (red) for
OLs (PLP), astrocytes (GFAP), or neurons (NeuN) showed that MASS1 is en-
riched in myelin-forming OLs. (C) PCR of cDNAs from different cell types
reveals that MASS1 is expressed in OLs and kidney cell lines (COS-7 and
HEK293T) but not in SVGp12 (astrocytes) or Neuro-2A (neurons) cells.
Fig. 2. MAG protein levels are dramatically reduced in the Fringsmouse. (A)
Western blots of whole-brain extracts from control and Frings mice at dif-
ferent developmental stages show that MAG levels are reduced in the mu-
tant Frings mice, but other myelin proteins, such as MBP, MOG, CNPase, and
PLP, are not affected by the absence of MASS1 at different times (p1, p21,
and p32). p, postnatal day. (B) OPCs were purified from both control and
Frings mice and then differentiated into mature OLs for 5 d. MAG protein
levels were dramatically decreased in mature OLs of Frings mice, whereas
mRNA levels were not different. (C) Immunohistochemical analysis revealed
reduced MAG expression in the SC and IC in Frings mice compared with
control, but not in the corpus callosum. A glial marker (CC1) was used to
define the glial cell population. (D) Mature OLs from Frings and control mice
were stained for mature OL markers (MBP and GalC) and showed no obvious
differences.
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different time points and showed that MAG degradation is
slower in cells cotransfected with miniMass1 vs. control, in-
dicating that MASS1 decreases MAG degradation in vitro (Fig.
3B). Treatment with a proteasomal inhibitor (MG132) in cells
cotransfected with miniMass1 showed significantly higher MAG
levels than in nontreated cells (Fig. 3C). In all cases (Fig. 3 A–C)
the cells were maintained in calcium-free DMEM with 0.1%
serum before calcium treatment. It is possible that higher expres-
sion of MAG, even with 0 mM Ca2+, resulted from a trace amount
of calcium in the serum (0.1%) that is necessary to maintain cell
viability. In addition, MG132 treatment did not affect the MAG
levels in samples coexpressed with MASS1 C terminus or empty
vector, suggesting that MASS1 slows proteasomal degradation of
MAG and that the extracellular region of MASS1 is critical for this
effect. Next, we examined ubiquitylation of MAGwhen coexpressed
with mini-MASS1 and HA-ubiquitin. Immunoprecipitation of
MAG from extracts and Western blot analysis against ubiquitin
showed increased ubiquitylated MAG in the absence of calcium,
suggesting that mini-MASS1 blocks MAG ubiquitylation in
a calcium-dependent manner (Fig. 3D). Expression of mini-
MASS1 lacking CalX-β repeats (Fig. S2A) did not result in in-
creased expression of MAG, implying that the calcium-binding
repeats of MASS1 are necessary for regulation of MAG levels
(Fig. 4A). Interestingly, MAG is expressed at lower levels in cells
of mini-MASS1ΔCalX-β compared with empty vector control,
suggesting that mini-MASS1ΔCalX-β might have a dominant-
negative effect on MAG regulation.
To further assess whether repression of endogenous MASS1
reduces MAG levels, we used Mass1-specific siRNA duplexes
to suppress MASS1 expression and efficiently reduced Mass1
expression in Mass1-positive cells (oli-neu) (Fig. S3). Trans-
fection of MASS1 siRNAs in COS-7 cells cotransfected with
MAG and in S16 (Schwann cell line) and oli-neu (OL cell line)
cells expressing endogenous MAG led to dramatically reduced
MAG levels (Fig. 4B). To confirm the MAG regulation by
MASS1 in OLs, we exposed primary differentiated OLs from
control and Frings (Mass1-null) mice to different concentrations
of calcium. MAG levels were significantly higher in control OLs
vs. Frings OLs (Fig. 4C). Together, these data suggest that
MASS1 inhibits the ubiquitylation and hence the degradation of
MAG in a calcium-dependent manner and that this effect
requires the extracellular region of MASS1.
Intracellular MASS1 Domains Interact with Gαs and Gαq. Because
MASS1 is a GPCR, we set out to characterize specific intracel-
lular signals that it regulates. We tested for interactions to iden-
tify the G proteins through which MASS1 signals. Because
subunits are critical for specificity of intracellular signaling (17),
we cloned α subunits that we were able to amplify from mouse
brain cDNAs (Fig. 5A) and tested each for interaction with the
intracellular regions of MASS1 using a GST pulldown assay.
Because G proteins interact with the third loop and/or C-terminal
region of MASS1, we cotransfected Gα protein clones with plasmids
expressing the third loop and C-terminal region of MASS1. In-
terestingly, both Gαs and Gαq isotypes bound to MASS1 (Fig. 5B).
Gαs activates adenylyl cyclase and up-regulates cAMP, whereas
Gαq protein activates the PKC pathway. Therefore, we postulated
that MASS1 regulates PKA and PKC signals via Gαs and
Gαq, respectively.
Fig. 3. MASS1 enhances MAG stability in a calcium-dependent manner. (A)
MAG plasmid was cotransfected into COS-7 cells with empty vector or
miniMass1. The cells were transferred to serum- and calcium-free media for
24 h and then treated with the indicated amounts of calcium for 1 h and
analyzed by Western blot analyses for MAG and GAPDH. Calcium levels in
the media correlated with MAG protein levels. MAG levels were increased in
the presence of mini-MASS1 compared with control. Data are expressed as
means of triplicate ± SD. (B) Cycloheximide (CHX) was used to monitor the
degradation rate of MAG. Pixel intensity of protein bands was quantified
using TINA software (Fuji) and plotted as normalized intensity units (Right).
The degradation of MAG is much slower in the presence of mini-MASS1
compared with empty vector, suggesting that mini-MASS1 stabilizes MAG
protein. Data are expressed as means of triplicate ± SD. (C ) After trans-
fection and 24 h starvation, cells were treated with 10 μM MG132 with the
indicated calcium levels for 5 h. Mini-MASS1 greatly increases the effect of
MG132 on MAG stabilization. (D) Cells were cotransfected with HA-tagged
ubiquitin and the indicated plasmids, lysed, immunoprecipitated with MAG
antibody, blotted, and probed with HA antibody. Higher calcium levels
suppress the ubiquitin modification of MAG protein.
Fig. 4. Either absence of MASS1 or calcium-binding domains of MASS1
abolishes the enhanced MAG expression. (A) mini-MASS1, with or without
CalX-β repeats, and empty vector were coexpressed with MAG in HEK293T
cells. Cells expressing mini-MASS1 show increased MAG expression, and re-
moval of the CalX-β domains abrogates this effect. Quantification of MAG
proteins is shown below. Data are expressed as means of triplicate ± SD. (B)
Introduction of siRNA targeting MASS1 results in the suppression of both
exogenous (COS-7) and endogenous (S16 Schwann cell and oli-neu oligo-
dendrocytes) MAG expression, indicating that the suppression of endoge-
nous MASS1 destabilizes MAG protein. (C) OPC cells were purified from both
Frings and control mice and differentiated into mature OL cells for 5 d, se-
rum starved without calcium for 5 h, and then treated with the indicated
amount of calcium for 1 h. Lysates were immunostained with MAG and
GAPDH antibodies. A dramatic increase in MAG levels was noted in the
control OLs compared with the Frings OLs. Data are expressed as means of
triplicate ± SD.
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Calcium-Dependent Regulation of PKA and PKCδ/θ by MASS1. Be-
cause PKA activity is dependent on cAMP levels in the cell, we
transfected miniMass1 either containing or lacking CalX-β re-
peats and empty vector into COS-7 cells with four representative
Gα proteins (Gαs, Gαi2, Gαq, and Gα12) and empty plasmid. After
serum starvation in calcium-depleted media, 7.5 mM calcium
was added to the media for 1 h, and intracellular cAMP was
measured by ELISA. Higher cAMP levels were seen when
mini-MASS1 was expressed compared with mini-MASS1ΔCalX-β
or empty vector regardless of Gα proteins, suggesting that mini-
MASS1 up-regulates intracellular cAMP levels via endogenous
Gα proteins. Coexpression of Gαs protein with mini-MASS1
resulted in the highest cAMP concentrations compared with Gαi2,
Gαq, Gα12, or vector control (Fig. 5C and Fig. S4), indicating that
calcium-dependent MASS1 signaling regulates cAMP via Gαs.
To investigate MASS1 regulation of PKC via Gαq, phospho-
specific PKC antibodies were used to detect activation of specific
PKC isozymes. Calcium was used to activate MASS1 in HEK293T
cells transfected with exogenous miniMass1 orMass1 C terminus.
Because the MASS1 C terminus has neither extracellular nor
transmembrane domains (Fig. S2A), it cannot receive extracel-
lular signals directly and was therefore used as a negative control
for the effect of intracellular calcium. Cells were treated with
calcium for 1 h after serum starvation, and the phosphorylation
status of PKC isozymes was monitored by Western blot analyses
using phospho-specific antibodies. Interestingly, PKCδ and
PKCθ were specifically up-regulated only in the presence of both
mini-MASS1 and calcium (Fig. 5D). Three phosphorylation sites
are sufficient for fully activated PKC isozymes (18). We found
that a threonine in the activation site (T505 or T538), which
plays a critical role in overall catalytic activity and regulates other
phosphorylations of hydrophobic/turn motif regions in PKCδ/θ
(18), is hyper-phosphorylated relative to empty vector and MASS1
C terminus controls. Because MASS1 is expressed endogenously
in HEK293T cells (Fig. 1C), empty vector and MASS1 C terminus
controls also increased the phosphorylation of the activation site
(T505 or T538) in PKCδ/θ, although to a lesser extent than the
sample transfected with mini-MASS1. We further asked whether
calcium-binding domains mediate PKC activation. After trans-
fecting miniMass1 and miniMass1ΔCalX-β into HEK293T cells,
we checked the phosphorylation status of PKCδ/θ using the same
conditions (above). As seen in Fig. 5E, activating phosphorylations
of PKCδ/θ were much less robust in the presence of mini-
MASS1ΔCalX-β. Taken together, these data show that MASS1
regulates PKC signaling in a calcium-sensitive manner.
Absence of MASS1 Prevents MAG Regulation. PKC was previously
shown to play a role in regulating myelin proteins levels (19). To
further reveal the mechanism and assess MASS1 regulation of
PKC in vivo, we used primary OL cultures and found that
phosphorylated PKCδ/θ levels were dramatically decreased in
Frings OLs vs. control (Fig. 5F). For PKA activation, the catalytic
subunits of PKA must be phosphorylated, which occurs on
threonine 197 (T197) and helps orientate catalytic residues in the
active site of PKA (20). The phosphorylation of PKA at T197
was dramatically reduced in primary cultured mouse embryonic
fibroblast cells (MEFs) of the Frings compared with that of
control mice (Fig. 5G). Furthermore, phosphorylation at serine
133 of cAMP responsive element binding protein (CREB) that is
a substrate of PKA (21) was increased by the addition of calcium
(control siRNA), whereas this propensity was absent in oli-neu
cells treated with Mass1-siRNA (Fig. 5H). These results imply
that endogenous MASS1 may regulate MAG stability via PKC
and PKA in myelin-forming cells. To confirm the specificity of
PKC signaling on MAG regulation, we treated cell cultures with
a specific PKCδ/θ inhibitor, Rottlerin (22), at different doses in
Fig. 5. MASS1 activates PKA and PKCδ/θ in response to extracellular calcium via Gαs/Gαq. (A) For the expression of 14 Gα proteins, each full coding sequence
was subcloned into FLAG-fusion vector (pCMV-Tag 4A). (B) FLAG-tagged Gα protein-encoding genes were cotransfected into HEK293T cells with clones
encoding the third cytoplasmic loop and carboxyl terminal region of MASS1 each fused to GST. The extracts were precipitated with GST-Sepharose beads and
analyzed by FLAG antibody. Both Gαs and Gαq were coimmunoprecipitated. (C) Four representative Gα proteins (Gαs, Gαi2, Gαq, and Gα12) and empty control
vector were cotransfected into COS-7 with miniMass1 or miniMass1ΔCalX-β. ELISA revealed that calcium-activated mini-MASS1 increases intracellular cAMP
via Gαs much more than controls (empty vector and miniMass1ΔCalX-β). Data are expressed as means of triplicate ± SD. (D) Activation of PKCδ/θ by MASS1.
Cells were transfected with empty vector, mini-MASS1, and MASS1 C terminus, without serum or calcium, and then treated with 7.5 mM calcium for 1 h.
Extracts were analyzed by Western blotting with various phospho-PKC antibodies. Novel PKC isozymes (PKCδ/θ) were up-regulated only in the presence of
both mini-MASS1 and calcium. (E) Comparing mini-MASS1 to mini-MASS1ΔCalX-β confirmed that specific activation of PKCδ/θ requires the calcium-binding
CalX-β repeats. (F) Mature OL lysates were used to test whether phospho-PKCδ/θ levels are affected by the absence of MASS1. Activation of both PKC δ and θ is
dramatically reduced in the Frings OLs. (G) The phosphorylation in the catalytic subunits of PKA (T197) was dramatically reduced, which is an indicator of PKA
activation, in primary cultured MEFs from Frings and control. (H) The phosphorylation of CREB (S133), a substrate of PKA, was increased by the addition of
calcium (control siRNA), whereas this propensity was absent in oli-neu cells treated with Mass1-siRNA.
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the presence or absence of mini-MASS1. Rottlerin, a compound
from Mallotus philippinensis, is known to inhibit protein kinases
with high specificity for PKCδ/θ (IC50 range of 3–6 μM), PKCα/
β/γ (IC50 range of 30–42 μM), and PKCe/ζ/η (IC50 range of 80–
100 μM) (22). Whereas MAG levels were significantly higher in
the presence of overexpressed MASS1 relative to control (empty
vector; only endogenous MASS1 present), MAG levels de-
creased in a dose-dependent manner by Rottlerin under both
conditions (Fig. 6A). Knockdown of Mass1 expression by siRNA
dramatically reduced the effect of Rottlerin (Fig. 6B). These
results suggest that MASS1-mediated PKA and PKCδ/θ act to-
gether as key regulators of MAG expression.
We next asked whether there is a direct correlation betweenGαs/
Gαq and MASS1-mediated MAG regulation. Overexpression of G
proteins with control siRNA in COS-7 cells resulted in higher
MAG levels for both Gαs and Gαq but not for Gαi2 and Gα12.
However, knockdown of MASS1 by siRNA blocked up-regulation
of MAG by Gαs and Gαq (Fig. 6 C andD). Thus, we concluded that
MASS1 up-regulates MAG expression via Gαs/Gαq.
Discussion
As we predicted years ago, most known Mendelian genes causing
nonsymptomatic epilepsies encode ion channels (23). MASS1 is
among the few known epilepsy genes that do not encode chan-
nels, suggesting that membrane hyperexcitability can arise in-
directly (24). The precise role of MASS1 is not known and, as an
orphan GPCR, its large size has been an obstacle for such studies.
Therefore, we used a minigene containing known or predicted
functional domains of MASS1. With this construct we investi-
gated intracellular signaling pathways associated with MASS1 func-
tion and found that MASS1 up-regulates PKA/PKC signaling in
a calcium-dependent manner, thus inhibiting MAG ubiquitylation
and degradation by the proteasome. To control for overexpression
effects of exogenous mini-MASS1, we showed similar regulation
of MAG by endogenous MASS1 in purified OLs.
Under physiological conditions, calcium concentrations are
regulated by homeostatic mechanisms such as the calcium sensing
receptor (25). The plasma membrane calcium-ATPase, the
Na+/Ca2+ exchanger, and Ca2+ permeable ion channels also
contribute to extracellular calcium homeostasis, largely as a
function of driving forces defined by ionic gradients. Although
these mechanisms function to maintain extracellular calcium,
decreases in extracellular calcium can occur in the brain as
a consequence of neuronal activity (particularly excessive activity
such as seizures). It is interesting to speculate that MASS1 might
function to monitor extracellular calcium levels and mediate
intracellular signaling events that enable cellular responses to
changes in the extracellular ionic environment in the CNS.
PKC is known to regulate steady-state levels of myelin pro-
teins such as MBP, PLP, MAG, CNPase, O4, and GALC. PKC-
mediated posttranscriptional suppression of myelin gene expres-
sion is most profound in differentiating OLs at or before the
onset of myelin protein synthesis (19). This correlates well with
our data showing that MASS1 regulates MAG protein stability.
PKC signaling has a proliferative effect on immature OLs and
increases process extension and myelin formation in mature OLs
(26). PKC activation also results in increased phosphorylation of
CNPase and MBP. cAMP and PKA signaling can induce MAG
and PLP expression and trigger the final stages of OL maturation
(27). We now show that MASS1 mediates MAG expression
through PKA and cAMP, suggesting that in addition to PKC,
a unique signaling pathway exists in OLs through which PKA
regulates MAG.
MAG is a functional ligand for the neurite outgrowth inhib-
itory protein (NOGO) receptor (NgR) (28) and is involved in the
process of myelination, cell adhesion, and signaling in myelin-
forming cells (29). MAG-deficient mice show developmental
abnormalities including multiple ensheathed axons, delayed mye-
lination, and dying-back oligodendrogliopathy in older mice (30),
but it is not known whether they have any seizure phenotype.
MAG is localized in periaxonal membranes of myelin sheath,
where it functions in the maintenance of periaxonal space and
ganglioside-mediated axon–glial interaction (29). In this study
there were no discenible changes in the gross structure of myelin,
even though we need to further characterize subtle myelin
changes. In another way, it might suggest it could affect gangli-
oside-mediated axon–glial interaction. The mice expressing only
monosialoganglioside GM3, which were generated by double
disruption of both GD3 synthase, a sialytransferase that synthe-
sizes b-series gangliosides, and 1,4-N-acetylgalatosaminyltransfer-
ase (GalNAcT), were extremely susceptible to induction of lethal
seizures by sound stimulus, indicating that gangliosides might play
an essential role in certain audiogenic seizure pathways (31).
Nerve cell surface gangliosides GD1a and GT1b are specific
functional ligands for MAG-mediated inhibition of neurite out-
growth, which gangliosides are synthesized from simpler pre-
cursors by the addition of GalNAc to the growing carbohydrate
chain via GalNAcT. Knockout mice with an inactivated GalNAcT
gene do not express GD1a and GT1b. Instead, these mice express
compensatory amounts of the simpler gangliosides GD3 (which is
not a MAG ligand) and GM3 (which binds MAG, but with lower
affinity than GD1a or GT1b) (32). Frings mice crossed with Gal-
NAcT knockout will provide better evidence for the involvement
of axon–glia interaction-mediated epileptic pathology.
Mass1 transcripts were reported to be highly expressed in re-
stricted regions of the developing CNS (33). Because MASS1 is
strongly expressed in the ventricular zone, a center of neural
progenitor cells during embryonic neurogenesis, MASS1 may
play a fundamental role in CNS development. In this study we
have shown that the MASS1 protein is also expressed in the SC
and IC of the adult brain. These regions are critical for initiation
and propagation of audiogenic seizures. Immunohistochemistry
for c-Fos in the Frings mouse showed audiogenic seizure-induced
transcriptional activation in neurons of the brainstem seizure
pathway, including the external and dorsal nuclei of IC (34). PKC
Fig. 6. MASS1 up-regulates MAG via PKA and PKCδ/θ. (A) MAG was ex-
pressed in COS-7 cells with mini-MASS1 and then treated with Rottlerin,
a specific PKCδ/θ inhibitor, for 16 h. Dose-dependent reductions in MAG
expression were seen with Rottlerin treatment, indicating that PKC activa-
tion is necessary for the regulation of MAG. Data are expressed as means of
triplicate ± SD. (B) Knockdown of Mass1 expression by siRNA dramatically
reduced the effect of Rottlerin on MAG regulation. (C) Loss of MASS1 by
siRNA abolishes Gαs/Gαq-mediated up-regulation of MAG expression. (D)
Densitometric quantification of MAG proteins was analyzed by TINA soft-
ware (Fuji) and indicated Gαs/Gαq-specific MAG up-regulation by MASS1.
Data are expressed as means of triplicate ± SD.
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can also transduce signals to the nucleus in OLs, activating tran-
scription of genes such as c-fos (35). Given high MASS1 protein
expression in SC and IC, we postulate that MASS1 regulates the
myelination of the SC and IC, and this myelination may be
modified by the absence of MASS1 and could be a contributor to
the epilepsy in Frings mice. However, preliminary data on myelin
structure of SC with fluoromyelin staining (Fig. S5) and electron
microscopy (Fig. S6) did not reveal any gross myelin abnormalities
such as altered g-ratio. Therefore, more detailed ultrastructural
morphometry of Frings mice is an important next step for char-
acterization of the axon and its surrounding myelin structure,
along with the audiogenic brainstem using transmission electron
microscopy. Besides MASS1, other well-known myelin-enriched
proteins, such as myelin protein zero, GALC, and inverted formin-
2 (INF2), are also expressed in the kidney with unknown func-
tions, except that INF2 is enriched in endoplasmic reticulum of
podocytes, where it might regulate membrane structure for fil-
tration complex (36). We speculate they are necessary in both
myelin-forming cells and kidney for unique membrane structures:
myelin sheath of brain and podocyte-filtration barrier of kidney.
Given the restricted expression of MASS1 protein in the SC
and IC, the null mutation of this gene causes alterations of MAG
abundance in the entire brain (Fig. 2). There are two possibili-
ties. First, it could present complex ganglioside-dependent re-
gional oligodendroglial heterogeneity, because MAG expression
is progressively and selectively regulated in the brains of mice
lacking complex brain gangliosides in a ganglioside-dependent
manner (37). Second, it could reflect the difference between
calcium-activated MAG up-regulation and degradation rates.
Under physiological conditions in brain, the dynamic changes of
calcium in response to environment may result in MAG accu-
mulation in the colliculi of normal control, owing to the differ-
ence of fast posttranscriptional up-regulation (Fig. 4C; 1 h for
a 2.5-fold increase) vs. slower degradation rates (Fig. 3B; >8 h of
half-life of MAG).
In summary, we have shown that MASS1 senses extracellular
calcium and activates PKA and PKC signaling via Gαs and Gαq
to regulate stability of MAG in myelin-forming cells. This study
provides insight into a unique pathway of myelin regulation
via a GPCR associated with audiogenic epilepsy. Hopefully,
such insights may ultimately lead to identification of novel
anticonvulsants.
Materials and Methods
Details for antibodies, chemicals, mice, immunochemistry, transmission
electron microscopy, in vitro binding and ubiquitylation assay, animal cell
culture, plasmids, and quantification of cAMP are provided in SI Materials
and Methods. All animal experiments were performed under approval by
the Animal Care and Use Committee at University of California, San Francisco.
ImageJ (NIH) or TINA (Fuji) software were used for densitometric analyses.
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SI Materials and Methods
Antibodies and Chemicals. Primary antibodies were monogenic
audiogenic seizure susceptible 1 [MASS1; Santa Cruz Bio-
technology and from Uwe Wolfrum, Johannes Gutenberg Uni-
versity of Mainz, Germany (1)], myelin-associated glycoprotein
(MAG; Zymed), NeuN/GFAP/myelin basic protein (MBP)
(Chemicon), proteolipid protein (PLP)/2′,3′-Cyclic-nucleotide 3′-
phosphodiesterase (CNPase) (Abcam), PKC/p-CREB-S133/CREB
(CREB, cAMP responsive element binding protein) (Cell Signal-
ing), HA/M2-Flag (Sigma), Fluoro-myelin (Molecular Probes) (2),
and myelin oligodendrocyte glycoprotein/GST (Santa Cruz Bio-
technology). All chemicals were purchased from Sigma unless
otherwise stated.Mass1-specific siRNA duplex and control siRNAs
were obtained from Invitrogen.
Mice. Experiments were conducted according to the protocols
approved by the Institutional Animal Care and Use Committee of
University of California, San Francisco (UCSF). Fringsmice were
from an in-house colony at UCSF. SWR/Bm mice were pur-
chased from the Jackson Laboratory. Because the Frings mice
have been maintained as an inbred line for more than 60 y,
SWR/Bm mice were used as controls because they are also de-
rived from the Swiss family and are the most closely related
known line to Frings (3).
Immunohistochemistry. Cryosections were prepared from 4%
paraformaldehyde-perfused control (SWR/Bm) and Frings mice
brains, permeabilized with Triton X-100, and blocked and in-
cubated overnight with primary antibodies. After washing with
PBS, sections were incubated with secondary Cy2- or Cy3-
labeled anti-mouse or -rabbit IgGs (Amersham). Samples were
washed with PBS (5 min each three times), and coverslips were
mounted with Vectashield (Vector Laboratories) mounting
medium and DAPI.
Transmission EM. EM for the analysis of myelin structure was
carried out as described previously (4). Briefly, mice were first
anesthetized with 2.5% avertin and then perfused with 4%
paraformaldehyde and 2.5% glutaldehyde in phosphate buffer
and incubated in fixative for 1 wk. After being postfixed, spinal
cords were dissected and embedded in Epon. Ultra-thin sections
were cut and stained with uranyl acetate and lead citrate and
then collected on grids. The pictures were taken with the
Tecnai electron microscope at the San Francisco VA Medical
Center EM Lab.
In Vitro Binding and Ubiquitylation Assay. For in vitro assays to
identify Gα protein(s) binding to MASS1, HEK293T cells were
transfected with each FLAG-tagged Gα and GST-tagged MASS1
C terminus (amino acid residues 6148–6298) and the third cy-
toplasmic loop (amino acid residues 6074–6097) or GST alone
(Figs. S2B and 4A). Twenty-four hours after transfection, lysates
were incubated for 1 h at room temperature with Glutathione
Sepharose 4B coated beads (Amersham) in lysis buffer [50 mM
Tris·Cl (pH 7.4), 100 mM KCl, 300 mM NaCl, 10 mM EDTA,
1% Triton X-100, phenylmethylsulfonyl fluoride (PMSF), and
protease inhibitors], washed three times with wash buffer (lysis
buffer containing 0.1% Triton X-100), and subjected to West-
ern blot analyses against FLAG and GST. To assess ubiq-
uitylation, HEK293T cells were transfected with HA-tagged
ubiquitin, MAG, and MASS1 (Fig. 3D). After transfection, cells
were serum-starved in DMEM devoid of calcium chloride (In-
vitrogen) for 24 h and incubated for 4 h with 10 μMMG132. Cell
lysates were immunoprecipitated with anti-MAG antibody,
washed three times with the above wash buffer, and subjected to
Western blot analysis against HA. The band density of each lane
was evaluated using TINA software (Fuji).
Animal Cell Culture. HEK293T, COS-7, and S16 cells were main-
tained in DMEM supplemented with 10% (vol/vol) FBS. Primary
oligodendrocyte progenitor cell (OPC) cultures were per-
formed according to the immunopanning method (4, 5). Briefly,
brains were obtained from postnatal day 7 mice, and the cere-
bellum and midbrain/hindbrain structures were removed by
crude dissection, digested in papain, sequentially im-
munopanned on Thy1.2 (Serotech), anti-galactocerebroside
(GalC; Chemicon), and then O4 antibody (Chemicon)-coated
plates to select GalC–O4+ OPCs. Purified OPCs were cultured
on poly-D-lysine–coated tissue culture dishes or chamber slides at
37 °C, 10% CO2 in DMEM containing human transferrin, BSA,
putrescine, progesterone, sodium selenite, N-acetyl-L-cysteine,
D-biotin, forskolin, bovine insulin (all from Sigma), glutamine,
sodium pyruvate, penicillin–streptomycin, B-27 supplement (all
from Invitrogen), Trace Elements B (Mediatech), and ciliary
neurotrophic factor (10 ng/mL; PeproTech). Proliferation me-
dium also contained OPC mitogens such as platelet-derived
growth factor AA and neurotrophin 3 (both from PeproTech),
whereas differentiation medium included triiodothyronine (T3;
Sigma) without OPC mitogens. Oli-neu cells were maintained in
SATO medium (DMEM containing N1, biotin, insulin, L-gluta-
mine, and horse serum). For differentiation to mature OLs, 1 mM
dbcAMP (Calbiochem, catalog no. 28745) was added to the SATO
medium for 5 d.
Plasmids. The cDNAs encoding MASS1, MAG, Gαz, Gα13, Gαolf,
Gαi1, Gαi2, Gαi3, Gαo, Gαt2, Gα11, Gα14, Gα15, Gαs, Gαq, and Gα12
were amplified from mouse brain total RNAs by RT-PCR, and
ligated into pCMVTag4A (Stratagene) or pEBG (mammalian
GST fusion vector) (6) (Fig. 5A and Fig. S2). We also used four
previously reported Gα plasmids (Gαs, Gαq, Gαi2, and Gα12),
which were obtained from American Type Culture Collection
and Henry Bourne (UCSF) (7, 8).
Quantification of cAMP. Intracellular cAMP was quantified using
a cAMP Assay kits (R&D Systems and Thermo Scientific) ac-
cording to the manufacturer’s protocols.
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Fig. S1. (A) The myelin fractions were purified from control and Frings mice and then the myelin protein complex was immunoprecipitated by using anti-MBP.
The precipitates were analyzed by Western blot against MBP and MASS1. It showed that MASS1 is present in the myelin fraction associated with MBP. The myelin
from the Frings mice did not show any MASS1 signals. (B) The purified myelin fractions were stained with Coomassie blue for the normalization of myelin.
Fig. S2. Exogenous MASS1 and MAG constructs. (A) MASS1 has a large ectodomain with 35 CalX-β repeats, 7 EAR repeats forming a putative β-propeller
folding structure, a pentraxin domain, a G protein coupled receptor (GPCR)-proteolytic site (GPS), and B-family 7 TM domains. Mini-MASS1 contains the
N terminus, four copies of CalX-β, one Pentraxin, seven EAR repeats, a GPS, a B-family 7 TM domain, and whole C terminus of endogenous MASS1. We have
also created constructs lacking four copies of the CalX-β domain (mini-MASS1ΔCalX-β) or having only the C terminus (MASS1 C terminus). (B) Full coding
sequences of MAG, MASS1 C terminus, and third cytoplasmic loop regions were subcloned into pEBG plasmids for the GST-tagged protein expressions in
mammalian cells.
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Fig. S3. Mass1 siRNAs dramatically suppressed the expression of MASS1 in oli-neu (MASS1 present) cells. Neuro-2A neuronal cells (MASS1 absent) were used as
a control to show the protein band is specific to MASS1.
Fig. S4. The evaluation of immunoenzymatic colorimetric cAMP detection. Fourteen Gα proteins (classified by Gαs, Gαi2, Gαq, and Gα12 classes) and empty
control vector (with or without calcium) were cotransfected into COS-7 with miniMass1 or miniMass1ΔCalX-β. Colorimetric enzymatic immunoassay against
cAMP revealed that calcium-activated mini-MASS1 increases intracellular cAMP primarily via Gαs class significantly more than controls (empty vector and
miniMass1ΔCalX-β).
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Fig. S5. Fluoro-myelin staining analyses on cryosections of control and Frings mice showed no gross difference in the myelin of the corpus callosum, cere-
bellum white matter tracts, and colliculus.
Fig. S6. (A) Electron microscopy analysis using 1-mo-old control and Fringsmice showed that there is no gross change in myelin structure of superior colliculus.
(B) There was no obvious change in the g-ratios between Frings and control.
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